Table 2 Incremental costs and QALYs of returning individual incidental findings for a 45-year-old generally healthy individual, a 45-year-old individual with cardiomyopathy, or a 50-year-old patient with colorectal cancer

From: The cost-effectiveness of returning incidental findings from next-generation genomic sequencing